Zhenzhen Jiang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Zhenzhen Jiang has a total of 17 co-authors. Here are the top co-authors by number of shared publications:
- Xiatian Liu
Department of Ultrasound Shaoxing People's Hospital Shaoxing China
4 shared publications Jianbo Zhu
Department of Echocardiography, Shaoxing People’s Hospital
2 shared publicationsLei Zhu
Department of Echocardiography, Shaoxing People’s Hospital
2 shared publicationsAnni Chen
Department of Medicine, University of Shaoxing, Shaoxing, China
1 shared publicationChen Ni
Department of Echocardiography, The First Affiliated Hospital, Shaoxing University
1 shared publicationDi-Jia Ni
Department of Ultrasound, Shaoxing People’s Hospital, The First Affiliated Hospital of Shaoxing University, Shaoxing, China
1 shared publication
Latest Publications
- Open Access
- 28 October 2026
- Published by Frontiers Media SA in Frontiers in Cardiovascular Medicine
- Vol. 13, 1951089
Development and evaluation of a transesophageal echocardiography–derived left atrial appendage structure–function coupling index across the atrial fibrillation disease continuum
Background: Atrial fibrillation (AF) is a progressive disorder associated with atrial remodeling and thromboembolic risk. We developed a transesophageal echocardiography (TEE)-derived left atrial appendage (LAA) structure-function coupling index (LAA-SFCI), defined as LAA volumetric load relative to longitudinal deformation, and assessed its distribution along the AF disease continuum and its potential for risk re-stratification of patients without documented AF. Methods: This single-center, prospective, cross-sectional study included 267 patients undergoing clinically indicated TEE, classified by the 2023 American College of Cardiology/American Heart Association/American College of Clinical Pharmacy/Heart Rhythm Society (ACC/AHA/ACCP/HRS) framework as Stage 1 ( n = 68), Stage 2 ( n = 65), Stage 3a ( n = 66), or Stage 3b ( n = 68). Seven candidate LAA-SFCIs were calculated as the LAA volume index (LAA-VI) divided by a functional measure, and the principal index was selected by ordinal logistic regression using the Akaike information criterion. Discrimination was compared using the DeLong test and internally validated by bootstrapping, and patients without documented AF (Stages 1–2) were stratified by the exploratory cutoff. Results: LAA-VI/LAA-GLS (LAA global longitudinal strain) provided the best model fit and rose across AF stages from 0.33 ± 0.11 to 0.86 ± 0.36 (mL/m 2 )/% ( P < 0.001). In ordinal regression with the log-transformed index, each 1-SD increase remained associated with higher AF stage after adjustment for age, sex, body mass index, left ventricular ejection fraction, and left atrial volume index (odds ratio 11.04, 95% confidence interval 7.17–16.98). For Stage 1–2 versus Stage 3a–3b, its area under the curve (0.904; optimism-corrected 0.900) was significantly higher than those of LAA-VI (0.661) and LAA-GLS (0.824) (both DeLong P < 0.001). Among 133 patients without documented AF, 18 (13.5%) exceeded the cutoff of 0.460 (mL/m 2 )/%; these patients did not differ from the others in left atrial volume index or age. Conclusion: In this cross-sectional study, LAA-VI/LAA-GLS characterized LAA structure–function uncoupling along the AF disease continuum. In patients without documented AF undergoing clinically indicated TEE, it identified a subgroup with an AF-like LAA phenotype not captured by conventional atrial size measures. These findings are hypothesis-generating and require external validation and longitudinal follow-up to determine their prognostic value.
- 28 October 2026
- Published by Frontiers Media SA in Frontiers in Cardiovascular Medicine
- Vol. 13, 1951089
Open AccessDevelopment and evaluation of a transesophageal echocardiography–derived left atrial appendage structure–function coupling index across the atrial fibrillation disease continuum
Background: Atrial fibrillation (AF) is a progressive disorder associated with atrial remodeling and thromboembolic risk. We developed a transesophageal echocardiography (TEE)-derived left atrial appendage (LAA) structure-function coupling index (LAA-SFCI), defined as LAA volumetric load relative to longitudinal deformation, and assessed its distribution along the AF disease continuum and its potential for risk re-stratification of patients without documented AF. Methods: This single-center, prospective, cross-sectional study included 267 patients undergoing clinically indicated TEE, classified by the 2023 American College of Cardiology/American Heart Association/American College of Clinical Pharmacy/Heart Rhythm Society (ACC/AHA/ACCP/HRS) framework as Stage 1 ( n = 68), Stage 2 ( n = 65), Stage 3a ( n = 66), or Stage 3b ( n = 68). Seven candidate LAA-SFCIs were calculated as the LAA volume index (LAA-VI) divided by a functional measure, and the principal index was selected by ordinal logistic regression using the Akaike information criterion. Discrimination was compared using the DeLong test and internally validated by bootstrapping, and patients without documented AF (Stages 1–2) were stratified by the exploratory cutoff. Results: LAA-VI/LAA-GLS (LAA global longitudinal strain) provided the best model fit and rose across AF stages from 0.33 ± 0.11 to 0.86 ± 0.36 (mL/m 2 )/% ( P < 0.001). In ordinal regression with the log-transformed index, each 1-SD increase remained associated with higher AF stage after adjustment for age, sex, body mass index, left ventricular ejection fraction, and left atrial volume index (odds ratio 11.04, 95% confidence interval 7.17–16.98). For Stage 1–2 versus Stage 3a–3b, its area under the curve (0.904; optimism-corrected 0.900) was significantly higher than those of LAA-VI (0.661) and LAA-GLS (0.824) (both DeLong P < 0.001). Among 133 patients without documented AF, 18 (13.5%) exceeded the cutoff of 0.460 (mL/m 2 )/%; these patients did not differ from the others in left atrial volume index or age. Conclusion: In this cross-sectional study, LAA-VI/LAA-GLS characterized LAA structure–function uncoupling along the AF disease continuum. In patients without documented AF undergoing clinically indicated TEE, it identified a subgroup with an AF-like LAA phenotype not captured by conventional atrial size measures. These findings are hypothesis-generating and require external validation and longitudinal follow-up to determine their prognostic value.
- Open Access
- 29 December 2025
- Published by Springer Nature in BMC Medical Imaging
- Vol. 25 (1) , 512
Diagnostic value of shear wave elastography for diabetic peripheral neuropathy: comparison between junior radiologists and senior radiologists
Background: Diabetic peripheral neuropathy (DPN) is a prevalent complication of diabetes mellitus, and is often underdiagnosed because of its variable clinical presentation and operator–dependent diagnostic tools. Shear wave elastography (SWE), which quantitatively evaluates tissue stiffness, has the potential to enhance conventional ultrasound by improving diagnostic accuracy and consistency. Nevertheless, a comprehensive analysis examining the extent to which the integration of SWE with conventional ultrasound can enhance the diagnostic performance of radiologists across varying levels of expertise has yet to be performed. Methods: In this study, a total of 458 lower extremities from patients with type 2 diabetes were examined via ultrasound and SWE. Four radiologists (two seniors and two juniors) independently assessed the grayscale ultrasound, SWE, and combined images. Diagnostic performance was compared via receiver operating characteristic (ROC) curves and sensitivity and specificity metrics. Results: SWE measurements revealed significantly greater stiffness of the tibial nerve in the DPN group than in the non-DPN group, with values of 37.30 kPa versus 25.40 kPa ( P < 0.001) and corresponding shear wave velocities of 3.54 m/s versus 2.90 m/s ( P < 0.001). The combined images improved diagnostic accuracy across all readers. Notably, junior radiologists exhibited a substantial improvement in terms of sensitivity (ΔSensitivity = 25.565, 95% CI: 18.477–32.653, P = 0.004). In contrast, for the senior radiologists, neither the sensitivity nor the specificity significantly increased with increasing integration SWE. Conclusion: Combining SWE with conventional ultrasound improves the diagnostic accuracy for DPN and helps reduce performance gaps between junior and senior radiologists. SWE may serve as an effective adjunct to support early detection and consistent evaluation of DPN in clinical practice.
- 29 December 2025
- Published by Springer Nature in BMC Medical Imaging
- Vol. 25 (1) , 512
Open AccessDiagnostic value of shear wave elastography for diabetic peripheral neuropathy: comparison between junior radiologists and senior radiologists
Background: Diabetic peripheral neuropathy (DPN) is a prevalent complication of diabetes mellitus, and is often underdiagnosed because of its variable clinical presentation and operator–dependent diagnostic tools. Shear wave elastography (SWE), which quantitatively evaluates tissue stiffness, has the potential to enhance conventional ultrasound by improving diagnostic accuracy and consistency. Nevertheless, a comprehensive analysis examining the extent to which the integration of SWE with conventional ultrasound can enhance the diagnostic performance of radiologists across varying levels of expertise has yet to be performed. Methods: In this study, a total of 458 lower extremities from patients with type 2 diabetes were examined via ultrasound and SWE. Four radiologists (two seniors and two juniors) independently assessed the grayscale ultrasound, SWE, and combined images. Diagnostic performance was compared via receiver operating characteristic (ROC) curves and sensitivity and specificity metrics. Results: SWE measurements revealed significantly greater stiffness of the tibial nerve in the DPN group than in the non-DPN group, with values of 37.30 kPa versus 25.40 kPa ( P < 0.001) and corresponding shear wave velocities of 3.54 m/s versus 2.90 m/s ( P < 0.001). The combined images improved diagnostic accuracy across all readers. Notably, junior radiologists exhibited a substantial improvement in terms of sensitivity (ΔSensitivity = 25.565, 95% CI: 18.477–32.653, P = 0.004). In contrast, for the senior radiologists, neither the sensitivity nor the specificity significantly increased with increasing integration SWE. Conclusion: Combining SWE with conventional ultrasound improves the diagnostic accuracy for DPN and helps reduce performance gaps between junior and senior radiologists. SWE may serve as an effective adjunct to support early detection and consistent evaluation of DPN in clinical practice.
- Open Access
- 26 December 2025
- Published by Wolters Kluwer Health in Medicine
- Vol. 104 (52) , e46804
An acute pelvic pain in high-altitude tourist: A case report of ruptured ectopic pregnancy with low β-human chorionic gonadotropin
Rationale: High-altitude acclimatization triggers physiological adaptations – such as increased ventilation, heart rate, and red blood cell production – to improve tissue oxygen delivery. These adaptations may obscure typical signs of hemorrhage, complicating the diagnosis of ruptured ectopic pregnancy in patients with low beta-human chorionic gonadotropin (β-hCG) levels. Patient concerns: A 31-year-old woman developed sudden pelvic pain and mild vaginal bleeding on the third day of high-altitude travel (Qinghai-Tibet Plateau). Diagnoses: Initial evaluation at a local hospital indicated very low β-hCG and no intrauterine gestational sac, leading to a misdiagnosis of biochemical pregnancy. Hemoglobin stability and absence of red blood cell decline, combined with high-altitude physiological changes, further delayed diagnosis. A transvaginal ultrasound later identified a ruptured right fallopian tube ectopic pregnancy, confirmed surgically. Interventions: Surgical confirmation. Outcomes: The case underscores how high-altitude hematologic adaptations (e.g., masked anemia) and low β-hCG levels can mimic benign conditions, complicating timely detection. Lessons: Ectopic pregnancy should remain a differential diagnosis in high-altitude travelers with abdominal pain, even with low β-hCG and stable hematologic parameters. Clinicians should be vigilant for ectopic pregnancy even with low β-hCG and stable hemoglobin in high-altitude travelers, as acclimatization may mask hemorrhagic signs.
- 26 December 2025
- Published by Wolters Kluwer Health in Medicine
- Vol. 104 (52) , e46804
Open AccessAn acute pelvic pain in high-altitude tourist: A case report of ruptured ectopic pregnancy with low β-human chorionic gonadotropin
Rationale: High-altitude acclimatization triggers physiological adaptations – such as increased ventilation, heart rate, and red blood cell production – to improve tissue oxygen delivery. These adaptations may obscure typical signs of hemorrhage, complicating the diagnosis of ruptured ectopic pregnancy in patients with low beta-human chorionic gonadotropin (β-hCG) levels. Patient concerns: A 31-year-old woman developed sudden pelvic pain and mild vaginal bleeding on the third day of high-altitude travel (Qinghai-Tibet Plateau). Diagnoses: Initial evaluation at a local hospital indicated very low β-hCG and no intrauterine gestational sac, leading to a misdiagnosis of biochemical pregnancy. Hemoglobin stability and absence of red blood cell decline, combined with high-altitude physiological changes, further delayed diagnosis. A transvaginal ultrasound later identified a ruptured right fallopian tube ectopic pregnancy, confirmed surgically. Interventions: Surgical confirmation. Outcomes: The case underscores how high-altitude hematologic adaptations (e.g., masked anemia) and low β-hCG levels can mimic benign conditions, complicating timely detection. Lessons: Ectopic pregnancy should remain a differential diagnosis in high-altitude travelers with abdominal pain, even with low β-hCG and stable hematologic parameters. Clinicians should be vigilant for ectopic pregnancy even with low β-hCG and stable hemoglobin in high-altitude travelers, as acclimatization may mask hemorrhagic signs.
- Open Access
- 19 December 2025
- Published by Frontiers Media SA in Frontiers in Cardiovascular Medicine
- Vol. 12, 1616241
Diaphragmatic downward excursion as a novel metric for assessing Valsalva maneuver efficacy in patent foramen ovale detection by contrast transthoracic echocardiography
Objective: Contrast transthoracic echocardiography (c-TTE) is widely used for the diagnosis of patent foramen ovale (PFO), where the Valsalva maneuver (VM) serves as the standard provocative maneuver to optimize detection. This study aimed to evaluate diaphragmatic downward excursion (DDE) as a novel c-TTE–based parameter for objectively quantifying VM efficacy, thereby establishing a standardized assessment metric. Methods: We studied 145 patients with high clinical suspicion of PFO-related conditions. All participants underwent both c-TTE and contrast transesophageal echocardiography (c-TEE) examinations. Based on intraoral expiratory pressure exceeding 40 mmHg under c-TTE, patients were divided into adequate Valsalva maneuver (AVM) group ( n = 90) and non-adequate Valsalva maneuver (non-AVM) group ( n = 55). We compared the two groups in terms of DDE at the roof of the right atrium (DDE-RRA) and intracardiac hemodynamic parameters. Results: DDE-RRA was significantly lower in the AVM group than in the non-AVM group (7.3 mm vs. 3.1 mm, P < 0.001). ROC analysis identified 5 mm as the optimal cutoff value for evaluating VM efficacy, with a sensitivity of 77.8%, specificity of 92.7%, and an AUC of 0.90. The kappa test showed good agreement between DDE-RRA and insufflation manometry (kappa = 0.63, P < 0.001). Furthermore, the DeLong test demonstrated that the AUC of DDE-RRA was significantly greater than that of all assessed intracardiac hemodynamic parameters, including mitral and tricuspid peak E and A-wave velocities, as well as mitral and tricuspid velocity time integrals (all P < 0.05). Conclusion: DDE provides a simple and objective method for assessing VM efficacy under c-TTE, showing superior diagnostic performance compared with conventional intracardiac parameters. As this represents an initial attempt, further studies incorporating invasive validation are needed to confirm its clinical value.
- 19 December 2025
- Published by Frontiers Media SA in Frontiers in Cardiovascular Medicine
- Vol. 12, 1616241
Open AccessDiaphragmatic downward excursion as a novel metric for assessing Valsalva maneuver efficacy in patent foramen ovale detection by contrast transthoracic echocardiography
Objective: Contrast transthoracic echocardiography (c-TTE) is widely used for the diagnosis of patent foramen ovale (PFO), where the Valsalva maneuver (VM) serves as the standard provocative maneuver to optimize detection. This study aimed to evaluate diaphragmatic downward excursion (DDE) as a novel c-TTE–based parameter for objectively quantifying VM efficacy, thereby establishing a standardized assessment metric. Methods: We studied 145 patients with high clinical suspicion of PFO-related conditions. All participants underwent both c-TTE and contrast transesophageal echocardiography (c-TEE) examinations. Based on intraoral expiratory pressure exceeding 40 mmHg under c-TTE, patients were divided into adequate Valsalva maneuver (AVM) group ( n = 90) and non-adequate Valsalva maneuver (non-AVM) group ( n = 55). We compared the two groups in terms of DDE at the roof of the right atrium (DDE-RRA) and intracardiac hemodynamic parameters. Results: DDE-RRA was significantly lower in the AVM group than in the non-AVM group (7.3 mm vs. 3.1 mm, P < 0.001). ROC analysis identified 5 mm as the optimal cutoff value for evaluating VM efficacy, with a sensitivity of 77.8%, specificity of 92.7%, and an AUC of 0.90. The kappa test showed good agreement between DDE-RRA and insufflation manometry (kappa = 0.63, P < 0.001). Furthermore, the DeLong test demonstrated that the AUC of DDE-RRA was significantly greater than that of all assessed intracardiac hemodynamic parameters, including mitral and tricuspid peak E and A-wave velocities, as well as mitral and tricuspid velocity time integrals (all P < 0.05). Conclusion: DDE provides a simple and objective method for assessing VM efficacy under c-TTE, showing superior diagnostic performance compared with conventional intracardiac parameters. As this represents an initial attempt, further studies incorporating invasive validation are needed to confirm its clinical value.